Hamilton Lane (NASDAQ:HLNE) Given New $185.00 Price Target at UBS Group

Hamilton Lane (NASDAQ:HLNEGet Free Report) had its price target increased by equities research analysts at UBS Group from $150.00 to $185.00 in a research report issued to clients and investors on Tuesday, Benzinga reports. The brokerage currently has a “neutral” rating on the stock. UBS Group’s price target would indicate a potential upside of 5.33% from the company’s current price.

Other equities research analysts also recently issued research reports about the company. The Goldman Sachs Group boosted their price objective on Hamilton Lane from $139.00 to $147.00 and gave the company a “neutral” rating in a report on Thursday, October 3rd. JPMorgan Chase & Co. boosted their price target on shares of Hamilton Lane from $120.00 to $134.00 and gave the company a “neutral” rating in a research note on Wednesday, August 7th. Morgan Stanley raised their price objective on shares of Hamilton Lane from $140.00 to $182.00 and gave the company an “equal weight” rating in a research note on Thursday, October 10th. Keefe, Bruyette & Woods boosted their target price on shares of Hamilton Lane from $135.00 to $145.00 and gave the stock a “market perform” rating in a research report on Wednesday, August 7th. Finally, Wells Fargo & Company raised their price target on shares of Hamilton Lane from $156.00 to $170.00 and gave the company an “equal weight” rating in a research report on Wednesday, October 9th. Seven research analysts have rated the stock with a hold rating, Based on data from MarketBeat, the company has an average rating of “Hold” and an average target price of $160.50.

Read Our Latest Report on HLNE

Hamilton Lane Stock Down 1.2 %

Shares of NASDAQ HLNE opened at $175.64 on Tuesday. The company has a quick ratio of 2.72, a current ratio of 2.72 and a debt-to-equity ratio of 0.27. The firm has a market cap of $9.49 billion, a PE ratio of 47.60 and a beta of 1.19. The company’s fifty day simple moving average is $160.79 and its 200 day simple moving average is $136.84. Hamilton Lane has a 12-month low of $79.13 and a 12-month high of $181.96.

Hamilton Lane (NASDAQ:HLNEGet Free Report) last released its quarterly earnings data on Tuesday, August 6th. The company reported $1.51 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.10 by $0.41. Hamilton Lane had a net margin of 26.99% and a return on equity of 34.36%. The company had revenue of $196.73 million for the quarter, compared to analysts’ expectations of $149.84 million. During the same quarter in the prior year, the firm earned $0.94 EPS. As a group, sell-side analysts forecast that Hamilton Lane will post 4.88 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Hamilton Lane

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Covestor Ltd grew its holdings in shares of Hamilton Lane by 14,900.0% in the first quarter. Covestor Ltd now owns 300 shares of the company’s stock valued at $34,000 after acquiring an additional 298 shares in the last quarter. Quarry LP grew its stake in Hamilton Lane by 316.2% in the 2nd quarter. Quarry LP now owns 308 shares of the company’s stock valued at $38,000 after purchasing an additional 234 shares during the period. Signaturefd LLC increased its position in shares of Hamilton Lane by 13.1% during the 2nd quarter. Signaturefd LLC now owns 629 shares of the company’s stock valued at $78,000 after purchasing an additional 73 shares during the last quarter. CWM LLC increased its position in shares of Hamilton Lane by 24.7% during the 3rd quarter. CWM LLC now owns 505 shares of the company’s stock valued at $85,000 after purchasing an additional 100 shares during the last quarter. Finally, Fifth Third Bancorp raised its stake in shares of Hamilton Lane by 106.5% during the 2nd quarter. Fifth Third Bancorp now owns 694 shares of the company’s stock worth $86,000 after purchasing an additional 358 shares during the period. Hedge funds and other institutional investors own 97.40% of the company’s stock.

About Hamilton Lane

(Get Free Report)

Hamilton Lane Incorporated is a private equity firm specializing in early venture, emerging growth, turnaround, middle market, mature, mid-venture, bridge, buyout, distressed/vulture, loan, mezzanine in growth capital companies. It prefers to invest in energy, industrials, consumer discretionary, health care, real estate, information technology, utilities, and consumer services.

Featured Articles

Analyst Recommendations for Hamilton Lane (NASDAQ:HLNE)

Receive News & Ratings for Hamilton Lane Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hamilton Lane and related companies with MarketBeat.com's FREE daily email newsletter.